AT1R INHIBITORS TO TREATE COVID19 PATIENTS - CALL FOR ACTION

We are a group of doctors and researchers, that believe that AT1R antagonists, such as Losartan or Valsartan, will provide substantial clinical benefit to acutely ill SARS-CoV-2-infected patients.